SUMMARY A recently available kit for the determination of rubella haemagglutination inhibiting antibodies (Rubindex, Ortho Diagnostics) was compared with the method used routinely in this laboratory. Rubindex compared favourably in that no significant difference in titre was found in 95*1 % of 287 sera tested. Difficulty occurred with some sera from cases of Mycoplasma pneumoniae infection, rheumatoid arthritis, and a&small number of normal sera containing human 'O' cell agglutinins. This was overcome by treatment of the sera with 2-mercaptoethanol. Rubindex had the advantage that all reagents were provided in kit form and the trypsinised human 'O' cells provided had a longer shelf life than chick erythrocytes.
Since the original description of the rubella haemagglutination inhibition (HAI) test by Stewart et al. (1967) this test and minor modifications of it have formed the basis for the routine serological estimation of rubella antibodies.
The HAI test has formed an increasing part of the work load of most virus laboratories in the diagnosis of recent and past rubella infection. The detection of susceptible women of childbearing age is of particular importance since the advent of rubella vaccination.
Erythrocytes from pigeons and 1-day-old chicks were found to be the most suitable for the rubella HAI test (Halonen et al., 1967; Holmes and Warburton, 1967; Stewart et al., 1967) . More recently, trypsinised human 'O' cells have been shown to be at least as sensitive as, or more sensitive than, 1-day-old chick erythrocytes (Biddle, 1971; Quirin et al., 1972; Bannerman and Ross, 1973; Nelson et al., 1974; Iwakata et al., 1974 June 1975 and September 1975 ; 257 of these were from antenatal women, 41 were from medical students, six were from recent cases of Mycoplasma pneumoniae infection, and six were known to contain rheumatoid factor. The sera from antenatal patients were freshly received. All other sera had been stored at -20°C before testing. Category 2: 50 sera previously found to have no antibody on routine testing. These sera had been stored at -20°C. Category 3: six sera used for detection of rubellaspecific IgM. These sera were from patients known to have had a rubella rash 7-18 days before blood was taken. Infection was confirmed by rising antibody level.
Serum pre-treatment 0 3 ml of serum was added to 0-9 ml of 25 % acidwashed kaolin at pH 9 0 (Schmidt and Lennette, 1970) . The tubes were rotated on a roller drum for one hour at room temperature (RT) at 8 revolutions per hour and centrifuged at 1500 g for 20 minutes at Category 4 sera were pre-treated in the same manner as sera in other categories. Immediately before testing they were treated with 2-ME, as described in the standard method.
Rubella-specific IgM Six sera from convalescent cases of rubella were adsorbed with chick erythrocytes and group 0 human erythrocytes and tested by both methods after Evaluation of a new test system for rubella haemagglutination inhibiting antibodies sucrose density gradient centrifugation (Caul et al., 1974) .
Results
Of 403 routine sera tested, four were excluded from the results because titres were greater than 256 in one method and less than 256 in the other. There was insufficient serum to repeat these tests. Thirteen sera had titres greater than 256 by both methods and were not included as there were no comparable endpoints to the titrations. Three sera from Mycoplasma pneumoniae infections and three sera containing rheumatoid factor were excluded because they contained 'O' cell agglutinins of sufficient strength to interfere with the reading of Rubindex titres. It was later found that both these agglutinins and the agglutinins occasionally present in normal human sera could be readily removed by treatment with 2-ME, as used in the standard method. Fortythree additional sera (category 4) were tested by the Rubindex method with and without 2-ME to ascertain whether or not its use affected the titres. No significant difference (> two-fold) was observed. Fifty sera previously shown to contain no antibody by the standard method were repeated by both methods and all had titres of less than 1:8. The category 4 sera and the 50 negative sera were not included in the total of comparable results.
Of the 14 sera showing a four-fold or greater difference in titre between the two methods, eight were repeated at a later date, the other six being insufficient to re-test. When repeated, there was a variation in the titre from the original result in both methods. Six had identical titres by both methods and two had titres two-fold higher by Rubindex.
There was no significant difference in titre (> twofold) between the two methods in 95 1 % of 287 comparable routine sera.
Six sera were tested for the presence of rubellaspecific IgM after sucrose density gradient centrifugation. One of these contained 'O' cell agglutinins of sufficient strength to interfere with the reading of Rubindex results. Of the five comparable sera, two had an identical titre by both methods and three were two-fold lower using Rubindex. 2-ME was used in both methods to confirm that the antibody present was immunoglobulin class M. There was at least a six-fold drop in titre after 2-ME treatment in both methods.
Discussion
The use of kits in many fields of diagnostic laboratory work is increasing. Rubindex is a new addition to the range of kits available. When used in parallel with the standard method employed by this laboratory there was good correlation in titres between the two methods. The Rubindex system does have several advantages. Firstly, all reagents are standardised as a system, thereby giving a high degree of consistency. Secondly, the trypsinised human erythrocytes provided are stable for four weeks as opposed to a maximum of a few days for chick erythrocytes. They are provided ready for dilution.
A high proportion of the sera tested from cases of rheumatoid arthritis and from recent infections with Mycoplasma pneumoniae gave rise to non-specific haemagglutination in the Rubindex system. A few normal human sera produced a similar result. As some Mycoplasma pneumoniae infections and early rheumatoid conditions can clinically resemble rubella this can be of importance. The problem was overcome by the addition of 0 05 ml 0-5 M 2-mercaptoethanol. This method of removing non-specific agglutinins of immunoglobulin class M has been in use in this laboratory for several years, and a similar method has been described by Mortimer (1976) . The extra procedure was found to be very worthwhile in that it facilitated the reading of titres of a number of sera which would otherwise have been impossible. The addition of 2-ME had no significant effect on the titres obtained. Treatment with 2-ME would inactivate any rubella-specific IgM present in sera from recent rubella infections, but, in practice, a further specimen of serum would be requested in all such cases and a rise in titre obtained. This method of removing class M immunoglobulins with 2-ME treatment is an improvement on the method used by Smith and Cummins (1976) . It is more effective than adsorption with strong suspensions of indicator cells and also, in our standard method, avoids the possibility of introducing non-specific inhibitors from chick erythrocytes used in pre-adsorption of sera (Saeed and Murray, 1975) .
The Rubindex system was used to detect rubellaspecific IgM in six human sera after sucrose density gradient centrifugation. Despite pre-adsorption with human 'O' cells, one of these sera contained sufficient 'O' cell agglutinins to cause difficulty in reading. Rubindex detected IgM in the remaining five sera, with sensitivity equal to that of our standard method.
In conclusion, the Rubindex system was found to be reliable and reproducible and took slightly less time in serum pre-treatment than the standard method. We found little difference in sensitivity between the two methods. The kit form should make the system particularly welcome in smaller laboratories with limited time and facilities for preparing the reagents used in other methods. 
